Brief: Jazz Pharmaceuticals Upon Termination Of Deal Chimerix Will Be Required To Pay Termination Fee Of $35 Million In Cash
05/03/2025 12:50
March 5 (Reuters) - Chimerix Inc CMRX.O: JAZZ PHARMACEUTICALS:UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CHIMERIX WILL BE REQUIRED TO PAY CO TERMINATION FEE OF $35 MILLION IN CASH Source text: [ID:n0001193125-25-046226] Further company coverage: CMRX.O ((Reuters.Briefs@thomsonreuters.com;))